Sir,
A 14-year-old Chinese female who had a 2-month history of bilateral edema of the eyelids and lower limbs was admitted to hospital and diagnosed as having systemic lupus erythematosus (SLE). Her medical records included wheezing in the supine position over 2 years and skin eruption in the lower extremity over 1 year.
On physical examination, there was edema in bilateral eyelids and lower limbs without malar rash, oral ulcers or diffuse alopecia. The lower extremities showed bilateral ichthyosis-like skin lesions ( Figure 1 ). Pertinent laboratory findings included an erythrocyte sedimentation rate (ESR) of 90 mm/h, leukopenia (3.03 Â 10 9 /l, reference range 3.5-9.5 Â 10 9 /l), thrombocytopenia (98 Â 10 9 /l, reference range 125-350 Â 10 9 /l), and anemia (70 g/ l, reference range 115-150 g/l). The levels of Ca 2þ , P 3þ , and creatinine were normal. Serum vitamin D3, anti-cardiolipin antibodies, and myocardial enzymes were also normal. The urinary albumincreatinine ratio (ACR) was 2.01. Laboratory tests were positive for antinuclear antibodies (ANA) (titer 1:1000) with a nuclear homogeneity, antidouble stranded antibodies (dsDNA) (titer 1:980), anti-nucleosome antibodies, anti-histone antibodies, and anti-SSA antibody. Serum C3 and C4 levels were 0.21 g/l (reference range 0.9-1.8 g/l) and 0.069 g/l (reference range 0.1-0.4 g/l), respectively. The serum level of parathyroid hormone (PTH) was 233 pg/ml, (reference range 15-65 pg/ml). Scintigraphy of the parathyroid was shown to be normal by imaging agent Tc99m-MIBI ( Figure 2 ).
The imaging results showed pericardial effusion ( Figure 3 ). Echocardiography showed a liquid dark area in the left ventricular posterior wall (18 mm), left ventricle sidewall (17 mm), top of the right atrium (10 mm), thickness of the apex (10 mm), and right ventricular anterior wall (5 mm). A skin biopsy specimen from left leg skin demonstrated a hyperkeratotic stratum corneum with a diminished stratum granulosum. Epidermal tissue showed atrophy and superficial dilated dermal blood vessels ( Figure 4 ).
After admission, the patient immediately underwent a renal biopsy. We obtained two biopsy specimens, and each specimen with length of about 1 cm contained 100% cortex with six glomeruli. The mesangial area showed light-moderate proliferation with inflammatory cell infiltration with hematoxylin-eosin (HE) staining. Obvious proliferation of endothelial cells, thickening of capillary wall, and double-track sign were seen ( Figure 5 ). The renal biopsy specimen with Masson staining showed immune complexes deposited in the capillary wall with ''platinum ear'', and the glomerular capillary loop showed segmental necrosis ( Figure 6) .
A proliferated and enlarged mesangial area, proliferating endothelial cells, and irregular thickening of basement membrane of capillary were shown under electron microscopy. There were electrondense deposits in the mesangial area and under epithelial cells, and the foot process of podocytes showed diffused fusion. Tubular epithelial cells appeared swollen (Figure 7) .
Clinical manifestations, laboratory findings, and imaging results suggested SLE (WHO IV-Ga) complicated with acquired ichthyosis and secondary hyperparathyroidism. The patient was managed with high-dose methylprednisolone for 3 days (500 mg/d), then a standard dose of methylprednisolone (0.8 mg/kg/d) with other drugs was administered. The acquired ichthyosis was treated with emolliation and lactic acid lotion 12%. Fifteen days later, the patient could lie down without wheezing. The edema of the eyelids and lower extremities mitigated. The skin showed improvement at follow-up examination. White blood cells, platelets and hemoglobin increased to 8.9 Â 10 9 /l, 201 Â 10 9 /l and 93 g/l, respectively. ESR and ACR decreased to 31 mm/h and 0.97. The titer of ANA and dsDNA decreased to 1:340 and 1:260. Serum C3 and C4 levels decreased to 0.64 g/l and 0.13 g/l. The level of PTH decreased to 127 pg/ml.
Discussion
Ichthyosis, both hereditary and acquired, involves symmetric scaling of the skin, most prominently on the extensor surfaces of the extremities. 1 Acquired Figure 3 Cardiothoracic ratio increased significantly, large pericardial effusion. ichthyosis may be associated with malignancy, medication, and, rarely, autoimmune disease, and many systemic illnesses such as lymphoma, sarcoidosis, dermatomyositis, and SLE. The link between ichthyotic-appearing skin and autoimmune disorders is not entirely known, and exact pathways have not been successfully elucidated. Acquired ichthyosis may represent abnormal host immune responses, impaired lipogenesis or paraneoplastic consequences. 2 The first report of ichthyoticappearing skin seen in association with autoimmunity was in an adult female in 1980. 3 Acquired ichthyosis occurs mainly in adults, but in our report, the selected case was 14-year-old female with SLE. Although skin lesions are found in as many as 85% of patients with SLE, acquired ichthyosis is a rare cutaneous finding which is clinically and histologically distinguishable from ichthyosis vulgaris, since the latter involves trunk, face and scalp, the scales are very thick, lightreflecting, and adhere firmly to the skin, and the normal marking of palms and soles is exaggerated. Acquired ichthyosis can appear before other manifestations in patients with SLE, and the sudden appearance of ichthyosis has been considered a marker of systemic disease and should prompt further investigation. 4 In our report, the patient had skin ichthyosis eruption in the lower extremity for 1 year, but there were no classical clinical 
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The mesangial area is enlarged, there is endothelial cell proliferation, basement membrane has thickened, there are electron-dense deposits and the foot process is fused. manifestations or laboratory test results associated with SLE until edema and proteinuria appeared. SLE is an autoimmune disease that affects multiple organs, including the parathyroid glands, but secondary hyperparathyroidism with SLE is rarely reported. 5 Secondary hyperparathyroidism is characterized by elevated levels of PTH without primary parathyroid dysfunction and secondary to some diseases, for example, chronic kidney disease. In the present study, the patient did not have primary parathyroid disease and scintigraphy of the parathyroid was shown to be normal by imaging agent Tc99m-MIBI. The levels of serum calcium, phosphorus and serum creatinine were all normal, but concentration of PTH was higher than normal. After a period of specific treatment for SLE, PTH decreased significantly (from 233 pg/ml to 127 pg/ ml), which was associated with activity of SLE.
In conclusion, acquired ichthyosis and secondary hyperparathyroidism are both rare complications of SLE. With treatment of SLE, clinical manifestations of acquired ichthyosis and secondary hyperparathyroidism can be significantly improved, and an abnormal immune response may be involved in their pathogenesis. However, the specific pathophysiological mechanism remains to be elucidated.
